Global Health is currently trading at Rs. 1082.90, up by 9.55 points or 0.89% from its previous closing of Rs. 1073.35 on the BSE.
The scrip opened at Rs. 1119.75 and has touched a high and low of Rs. 1119.75 and Rs. 1068.50 respectively. So far 5635 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1513.75 on 16-Feb-2024 and a 52 week low of Rs. 815.40 on 09-Nov-2023.
Last one week high and low of the scrip stood at Rs. 1124.00 and Rs. 1049.70 respectively. The current market cap of the company is Rs. 29091.74 crore.
The promoters holding in the company stood at 33.04%, while Institutions and Non-Institutions held 23.31% and 43.65% respectively.
Global Health, which operates hospitals under the Medanta brand, has received approval from Board of Directors for signing of definitive agreement with Dr. Narayan Dutt Shrimali Foundation International Charitable Trust Society (Society) to operate and manage around 750 bedded hospital in Pitampura, New Delhi.
As per the agreement, the hospital building and associated civil infrastructure will be developed by the Society and Medanta will make the necessary investments in internal fitouts, MEP, furniture and medical equipment. Medanta is expected to incur a project capex of upto around Rs 600 crore in next 3-4 years, to be funded by a combination of internal accruals and debt financing.
Global Health is one of the largest private multi-speciality tertiary care providers operating in the North and East regions of India.
